Status: Not yet recruiting
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
This study aimed to investigate the value of a novel strategy of intermittent systematic chemotherapy (ISC) in widely metastatic nasopharyngeal carcinoma (wmNPC) patients who achieve objective response after systematic chemotherapy (SC).
Participants needed: 39
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Fujian Cancer HospitalUpdated: Mar 26, 2024
Eligibility criteria
Patients with multiple metastases at first diagnosis or multiple metastases afte... [+5]
Patients with a hypersensitivity to any of the drugs used in our study; [+10]